Page last updated: 2024-08-23

piperacillin and Cystic Fibrosis of Pancreas

piperacillin has been researched along with Cystic Fibrosis of Pancreas in 72 studies

Research

Studies (72)

TimeframeStudies, this research(%)All Research%
pre-199027 (37.50)18.7374
1990's9 (12.50)18.2507
2000's10 (13.89)29.6817
2010's22 (30.56)24.3611
2020's4 (5.56)2.80

Authors

AuthorsStudies
Alba, L; Chen, Y; Garber, E; Saiman, L; Tabibi, S; Zhou, J1
Bulitta, JB; Drusano, GL; Duffull, SB; Holzgrabe, U; Kinzig-Schippers, M; Sörgel, F; Stephan, U1
Christiansen, LE; Ciofu, O; Høiby, N; Kirkby, N; Mandsberg, LF; Poulsen, HE1
Hancock, RE; Kiffer, CR; Mendes, CM; Sampaio, JL; Schurek, KN; Sinto, S1
Brockow, K; de Monestrol, I; Gülen, T; Kowalik, A; Sorjonen, K1
Güler, N; Süleyman, A; Tamay, Z1
Engdahl, S; Pettit, RS; Riggsbee, D1
Demuyser, T; Echahidi, F; Olbrecht, M; Peeters, C; Piérard, D; Vandamme, P; Wybo, I1
Caverly, LJ; Huang, DB; Kalikin, LM; LiPuma, JJ; Spilker, T; Stillwell, T; Young, C1
Mayer, B; Roehmel, J; Salama, A; Schwarz, C; Specht, P; Staab, D1
LeCleir, LK; Pettit, RS1
Carlier, M; De Baets, F; Forier, K; Haerynck, F; Schelstraete, P; Stove, V; Van Braeckel, E; Van Daele, S; Van Heck, V; Van Simaey, L; Vaneechoutte, M; Verstraete, AG1
Barnes, MD; Becka, SA; LiPuma, JJ; Papp-Wallace, KM; Wilson, BM; Zeiser, ET1
El-Ghaiesh, S; Farrell, J; Hamlett, J; Jenkins, RE; Meng, X; Monshi, MM; Naisbitt, DJ; Park, BK; Peckham, D; Pirmohamed, M; Sanderson, JP; Whitaker, P; Yaseen, FS1
Peckham, D; Whitaker, P1
Beegle, S; Butterfield, JM; Farkas, J; Lodise, TP; Pai, MP; Rosen, J1
Aghazadeh, M; Hojabri, T; Hojabri, Z; Mahdian, R; Nahaei, MR; Pajand, O; Pirzadeh, T; Rahmati, M1
Diab Cáceres, L; Girón Moreno, RM; Marcos, MC1
Adelfred, A; Brock, B; Hardlei, TF; Jensen-Fangel, S; Kragh Thomsen, M; Nejatbakhsh, Y; Öbrink-Hansen, K; Petersen, E1
Mayer, B; Meinus, C; Roehmel, JF; Schwarz, C1
Brockhurst, MA; Davies, EV; James, CE; Winstanley, C1
Compain, F; Grohs, P; Kaibi, I; Lavollay, M; Mainardi, JL; Morand, P; Podglajen, I; Taieb, G1
Hebestreit, H; Kuhn, S; Kunzmann, S; Mayer, B; Thomas, W1
Cho, E; Davidson, AG; Lillquist, YP1
Conway, S; Earnshaw, C; El-Ghaiesh, S; Gooi, J; Jenkins, RE; Lavergne, SN; Meng, X; Monshi, M; Naisbitt, DJ; Park, BK; Peckham, D; Pirmohamed, M; Whitaker, P1
Ciombor, KK; Gehrie, E; Harris, N; Neff, AT; Seegmiller, AC; Young, PP1
El-Ghaiesh, S; Elsheikh, A; Farrell, J; French, N; Jenkins, R; Meng, X; Monshi, MM; Naisbitt, DJ; Park, BK; Peckham, D; Pirmohamed, M; Whitaker, P1
Naisbitt, D; Peckham, D; Whitaker, P1
Ampofo, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Waters, CD; Young, DC; Zobell, JT1
Marik, PE; Parekh, P1
Jones, RN; Mutnick, AH; Turner, PJ1
Arndt, PA; Chandrasekaran, V; Garratty, G; Hill, J; Kasper, M1
Den Hollander, JG; Jelliffe, RW; Mouton, JW; Overbeek, SE; Vinks, AA1
Belli, ML; Cruciani, M; Fenu, ML; Manno, G; Romano, L; Ugolotti, E1
Pitt, TL; Sparrow, M; Stefanidou, M; Warner, M1
Bertasi, S; Canuzzi, P; Crucitti, G; Grzejdziak, AD; Melis, E; Midulla, F; Quattrucci, S1
Batten, JC; Hodson, ME; Kennedy, HG; Stead, RJ2
Brock, PG; Roach, M1
Strandvik, B1
Neu, HC; Prince, AS2
Agostini, M; Barlocco, G; Bonomi, U; Borgo, G; Bozzino, L; Cabrini, G; Cappelletti, LM; Castellani, L; Conforti, M; Mastella, G1
Babin, S; Blessing-Moore, J; Hsu, YP; Lewiston, NJ; Moss, RB1
Braverman, S; Goldberg, M; Huang, NN; Keith, H; Palmer, J; Schidlow, D1
Fleming, PC; Gold, R; Isles, A; Jin, E; Levison, H1
Cox, FR; Flournoy, DJ1
Bryan, LE; Godfrey, AJ; Rabin, HR1
Høiby, N; Møller, NE1
Eriksen, KR; Feddersen, C; Flensborg, EW; Høiby, N; Møller, NE; Norn, S; Rosendal, K; Schiøtz, PO; Skov, PS1
Kaneshiro, WM; Lieberman, J1
Aronoff, SC; Klinger, JD1
Hoogkamp-Korstanje, JA; van der Laag, J1
Alpert, SE; Marx, CM1
Ciofu, O; Giwercman, B; Høiby, N; Pedersen, SS1
Martin, AJ; Roberts, G; Rye, PJ; Staugas, RE1
Francis, JL; Henry, RL; Wills, R1
Bingen, E; Bonacorsi, S; Fitoussi, F; Lhopital, S1
Fegan, CD; Stableforth, DE; Thickett, KM; Wildman, MJ1
Dyke, JW; Hay, MB; Kumar, A; Maier, GA1
Greene, LM; Harwood, IR; Kozakowski-Koch, JA; Rasor, JS1
Drusano, GL1
Moss, RB1
De Boeck, K; Eggermont, E; Smet, M1
Bentzon, MW; Høiby, N; Jensen, T; Koch, C; Pedersen, SS; Pressler, T; Rosdahl, VT1
Cambisano, W; Costantini, D; Crossignani, RM; Danza, ML; Giunta, A; Padoan, R; Trezzi, G1
Black, P; Blumer, J; Craft, JC; Halsey, NA; McCarty, JM; Tilden, SJ; Waring, W1
Aronoff, SC; Chiesa, C; Labrozzi, PH1
Grassi, GG1
Grassi, C1
Flux, M; Kramer, J; Laferriere, C; Marks, MI; Stutman, HR1
De Leo, C; Eftimiadi, C; Schito, GC1

Reviews

5 review(s) available for piperacillin and Cystic Fibrosis of Pancreas

ArticleYear
Drug induced complications; can we do more?
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2013, Volume: 12, Issue:6

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Aminoglycosides; Anti-Bacterial Agents; Comorbidity; Coronary Disease; Cystic Fibrosis; Diabetes Complications; Diabetes Mellitus; Disease Progression; Drug Hypersensitivity; Exocrine Pancreatic Insufficiency; Humans; Hypoglycemic Agents; Intestines; Magnetic Resonance Imaging; Microbiota; Patient Compliance; Piperacillin

2013
Nonimmediate β-lactam reactions in patients with cystic fibrosis.
    Current opinion in allergy and clinical immunology, 2012, Volume: 12, Issue:4

    Topics: Anti-Bacterial Agents; Ceftazidime; Cell Proliferation; Cystic Fibrosis; Desensitization, Immunologic; Drug Hypersensitivity; Humans; Male; Piperacillin; Skin Tests; T-Lymphocytes

2012
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins.
    Pediatric pulmonology, 2013, Volume: 48, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefepime; Ceftazidime; Cephalosporins; Clavulanic Acids; Cystic Fibrosis; Disease Progression; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin

2013
Respiratory infections: established therapy and its limitations.
    Clinical therapeutics, 1985, Volume: 7 Suppl A

    Topics: Aged; Anti-Bacterial Agents; Bronchiectasis; Bronchitis; Cystic Fibrosis; Empyema; Humans; Immunologic Deficiency Syndromes; Kinetics; Lung Abscess; Microbial Sensitivity Tests; Penicillin Resistance; Piperacillin; Pleurisy; Pneumonia; Pneumonia, Aspiration; Respiratory Tract Infections

1985
Respiratory infections: clinical evaluation.
    Clinical therapeutics, 1985, Volume: 7 Suppl A

    Topics: Amikacin; Carbenicillin; Cefotaxime; Cystic Fibrosis; Drug Therapy, Combination; Enterobacteriaceae; Haemophilus influenzae; Humans; Piperacillin; Pseudomonas Infections; Respiratory Tract Infections; Streptococcus; Streptococcus pneumoniae; Tobramycin

1985

Trials

10 trial(s) available for piperacillin and Cystic Fibrosis of Pancreas

ArticleYear
Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Computer Simulation; Cystic Fibrosis; Female; Half-Life; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Monte Carlo Method; Piperacillin; Population; Pseudomonas aeruginosa; Pseudomonas Infections

2007
Pharmacokinetics and pharmacodynamics of extended-infusion piperacillin/tazobactam in adult patients with cystic fibrosis-related acute pulmonary exacerbations.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Cystic Fibrosis; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Serum; Time Factors; Treatment Outcome; Young Adult

2014
Population pharmacokinetic analysis of nonlinear behavior of piperacillin during intermittent or continuous infusion in patients with cystic fibrosis.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:2

    Topics: Adult; Area Under Curve; Bayes Theorem; Cystic Fibrosis; Female; Half-Life; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Nonlinear Dynamics; Penicillins; Piperacillin

2003
Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A

    Topics: Adolescent; Alcohol Deterrents; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Cephalosporins; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Eosinophilia; Humans; Moxalactam; Penicillins; Piperacillin; Pseudomonas Infections; Random Allocation; Respiratory Tract Infections

1983
Comparative efficacy and tolerance study of azlocillin and carbenicillin in patients with cystic fibrosis: a double blind study.
    The Journal of antimicrobial chemotherapy, 1983, Volume: 11 Suppl B

    Topics: Adolescent; Adult; Azlocillin; Bacterial Infections; Carbenicillin; Child; Child, Preschool; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Penicillins; Piperacillin

1983
Piperacillin and tobramycin in the treatment of Pseudomonas lung infections in cystic fibrosis.
    The Journal of antimicrobial chemotherapy, 1983, Volume: 12, Issue:2

    Topics: Adolescent; Child; Cystic Fibrosis; Drug Therapy, Combination; Humans; Lung Diseases; Piperacillin; Pseudomonas Infections; Tobramycin

1983
Sensitization to aztreonam and cross-reactivity with other beta-lactam antibiotics in high-risk patients with cystic fibrosis.
    The Journal of allergy and clinical immunology, 1991, Volume: 87, Issue:1 Pt 1

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibodies, Anti-Idiotypic; Azlocillin; Aztreonam; Ceftazidime; Child; Child, Preschool; Cross Reactions; Cystic Fibrosis; Drug Hypersensitivity; Female; Humans; Immunoglobulin E; Immunoglobulin G; Male; Piperacillin; Skin Tests; Ticarcillin; Tobramycin

1991
Treatment of Pseudomonas lung infection in cystic fibrosis with piperacillin plus tobramycin versus ceftazidime monotherapy: preliminary communication.
    Pediatric pulmonology, 1989, Volume: 7, Issue:3

    Topics: Ceftazidime; Chronic Disease; Cystic Fibrosis; Drug Combinations; Forced Expiratory Volume; Humans; Leukocyte Count; Lung Diseases; Neutrophils; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Tobramycin; Vital Capacity

1989
Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosis.
    The Pediatric infectious disease journal, 1987, Volume: 6, Issue:7

    Topics: Adolescent; Adult; Analysis of Variance; Ceftazidime; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas; Pseudomonas Infections; Random Allocation; Sisomicin; Sputum

1987
Comparison of piperacillin alone versus piperacillin plus tobramycin for treatment of respiratory infections in children with cystic fibrosis.
    Pediatric pulmonology, 1988, Volume: 4, Issue:4

    Topics: Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Half-Life; Humans; Infant; Piperacillin; Pseudomonas Infections; Random Allocation; Respiratory Tract Infections; Sputum; Tobramycin

1988

Other Studies

57 other study(ies) available for piperacillin and Cystic Fibrosis of Pancreas

ArticleYear
Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3

    Topics: Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests

2007
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Cystic Fibrosis; DNA Repair; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Neutrophil Activation; Oxidation-Reduction; Oxidative Stress; Pseudomonas aeruginosa

2009
Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Genotype; Microbial Sensitivity Tests; Polymyxin B; Promoter Regions, Genetic; Pseudomonas aeruginosa; Transcription Factors

2009
Antibiotic hypersensitivity in cystic fibrosis - Low frequency of anaphylaxis over 16 000 courses.
    British journal of clinical pharmacology, 2022, Volume: 88, Issue:11

    Topics: Adult; Anaphylaxis; Anti-Bacterial Agents; beta-Lactams; Child; Cystic Fibrosis; Drug Hypersensitivity; Humans; Piperacillin; Retrospective Studies

2022
Antibiotic allergy in children with cystic fibrosis: A retrospective case-control study.
    Pediatric pulmonology, 2022, Volume: 57, Issue:11

    Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Case-Control Studies; Ceftazidime; Child; Ciprofloxacin; Cystic Fibrosis; Drug Hypersensitivity; Humans; Levofloxacin; Meropenem; Piperacillin; Retrospective Studies; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination

2022
Evaluation of the safety of piperacillin-tazobactam extended infusion in pediatric cystic fibrosis patients.
    Pediatric pulmonology, 2023, Volume: 58, Issue:4

    Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Humans; Infant, Newborn; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies

2023
    Antimicrobial agents and chemotherapy, 2023, 07-18, Volume: 67, Issue:7

    Topics: Achromobacter; Anti-Bacterial Agents; Cystic Fibrosis; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin; Tazobactam

2023
    Antimicrobial agents and chemotherapy, 2019, 12-20, Volume: 64, Issue:1

    Topics: Achromobacter; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Boronic Acids; Burkholderia; Cystic Fibrosis; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Stenotrophomonas; Stenotrophomonas maltophilia; Tazobactam

2019
Risk of piperacillin-induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study.
    Transfusion, 2019, Volume: 59, Issue:12

    Topics: Adult; Anemia, Hemolytic; Anti-Bacterial Agents; Cystic Fibrosis; Female; Humans; Middle Aged; Observational Studies as Topic; Piperacillin; Prospective Studies

2019
Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
    Pediatric pulmonology, 2017, Volume: 52, Issue:8

    Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin

2017
Development and validation of an LC tandem MS assay for the quantification of β-lactam antibiotics in the sputum of cystic fibrosis patients.
    The Journal of antimicrobial chemotherapy, 2018, Jan-01, Volume: 73, Issue:1

    Topics: Anti-Bacterial Agents; Aztreonam; Ceftazidime; Chromatography, High Pressure Liquid; Cystic Fibrosis; Humans; Meropenem; Piperacillin; Sputum; Tandem Mass Spectrometry; Thienamycins

2018
"Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant
    Journal of clinical microbiology, 2019, Volume: 57, Issue:8

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Burkholderia cepacia complex; Burkholderia gladioli; Burkholderia Infections; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Substitution; Humans; Kinetics; Microbial Sensitivity Tests; Piperacillin

2019
β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis.
    Chemical research in toxicology, 2013, Jun-17, Volume: 26, Issue:6

    Topics: Aztreonam; beta-Lactamase Inhibitors; beta-Lactams; Cystic Fibrosis; Drug Hypersensitivity; Haptens; Humans; Hypersensitivity; Meropenem; Molecular Structure; Piperacillin; Serum Albumin; T-Lymphocytes; Thienamycins

2013
Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2014, Volume: 24

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Burns; Cephalosporinase; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2014
Cystic Fibrosis and Piperacillin-tazobactam: Adverse Reactions.
    Archivos de bronconeumologia, 2015, Volume: 51, Issue:12

    Topics: Anti-Bacterial Agents; Cystic Fibrosis; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Young Adult

2015
Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2016, Volume: 15, Issue:2

    Topics: Anti-Bacterial Agents; Cystic Fibrosis; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2016
Piperacillin-induced mild haemolytic anaemia in a 44-year-old patient with cystic fibrosis.
    BMJ case reports, 2016, Oct-24, Volume: 2016

    Topics: Adult; Anemia, Hemolytic; Anti-Bacterial Agents; Cystic Fibrosis; Female; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2016
Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum model.
    BMC microbiology, 2017, 01-05, Volume: 17, Issue:1

    Topics: Bacteriophages; beta-Lactamases; Biodiversity; Biofilms; Biological Evolution; Culture Media; Cystic Fibrosis; Drug Resistance, Microbial; Penicillanic Acid; Phenotype; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tazobactam

2017
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4

    Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; Tazobactam; Thienamycins

2017
Immune-mediated severe hemolytic crisis with a hemoglobin level of 1.6 g/dl caused by anti-piperacillin antibodies in a patient with cystic fibrosis.
    Infection, 2010, Volume: 38, Issue:2

    Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Cystic Fibrosis; Drug Hypersensitivity; Female; Hemoglobins; Hemolysis; Humans; Piperacillin; Young Adult

2010
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2011, Volume: 10, Issue:3

    Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Burkholderia cepacia complex; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Colistin; Cystic Fibrosis; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Health Care Costs; Health Resources; Humans; Infant; Injections, Intravenous; Nebulizers and Vaporizers; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome

2011
Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis.
    Journal of immunology (Baltimore, Md. : 1950), 2011, Jul-01, Volume: 187, Issue:1

    Topics: Amino Acid Sequence; Antigens; Cell Line; Cell Proliferation; Chromatography, Liquid; Clone Cells; Cystic Fibrosis; Drug Hypersensitivity; Female; Haptens; Humans; Leukocytes, Mononuclear; Male; Molecular Sequence Data; Peptide Fragments; Peptides, Cyclic; Piperacillin; Protein Binding; Serum Albumin; Skin Tests; T-Lymphocytes; Tandem Mass Spectrometry

2011
Transfusion medicine illustrated. Profound piperacillin-mediated drug-induced immune hemolysis in a patient with cystic fibrosis.
    Transfusion, 2012, Volume: 52, Issue:1

    Topics: Anti-Bacterial Agents; Cystic Fibrosis; Female; Hemoglobins; Hemolysis; Humans; Piperacillin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult

2012
Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 341, Issue:3

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Antigen-Presenting Cells; beta-Lactams; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chemokine CCL4; Clone Cells; Cystic Fibrosis; Drug Hypersensitivity; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Humans; Interleukins; Lymphocyte Activation; Male; Mass Spectrometry; Piperacillin; Receptors, Antigen, T-Cell; Young Adult

2012
Life-threatening piperacillin-induced immune haemolysis in a patient with cystic fibrosis.
    BMJ case reports, 2013, Jan-04, Volume: 2013

    Topics: Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Cystic Fibrosis; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Young Adult

2013
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection.
    Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:3

    Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Critical Care; Cystic Fibrosis; Data Collection; Drug Resistance, Bacterial; Europe; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Population Surveillance; Proteus Infections; Proteus mirabilis; Tazobactam; Thienamycins

2002
Two cases of immune haemolytic anaemia, associated with anti-piperacillin, detected by the 'immune complex' method.
    Vox sanguinis, 2002, Volume: 83, Issue:3

    Topics: Adult; Anemia, Hemolytic; Antibodies; Coombs Test; Cystic Fibrosis; Drug Hypersensitivity; Fatal Outcome; Humans; Male; Piperacillin; Serologic Tests

2002
Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:1

    Topics: Bacteriological Techniques; Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Chi-Square Distribution; Child; Child, Preschool; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lactams; Male; Microbial Sensitivity Tests; Piperacillin; Rifampin; Sensitivity and Specificity

2003
Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents.
    Thorax, 2003, Volume: 58, Issue:9

    Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Resistance, Bacterial; Gentamicins; Humans; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

2003
Spondylodiscitis after bilateral sequential lung transplantation in a patient with cystic fibrosis.
    Transplant infectious disease : an official journal of the Transplantation Society, 2004, Volume: 6, Issue:1

    Topics: Adult; Ampicillin; Anti-Bacterial Agents; Cystic Fibrosis; Discitis; Female; Humans; Lung Transplantation; Piperacillin; Streptococcal Infections; Streptococcus; Treatment Outcome

2004
Adverse reactions to piperacillin in cystic fibrosis.
    Lancet (London, England), 1984, Apr-14, Volume: 1, Issue:8381

    Topics: Adult; Cystic Fibrosis; Female; Fever; Humans; Male; Piperacillin; Pseudomonas Infections

1984
Adverse reactions to piperacillin in cystic fibrosis.
    Lancet (London, England), 1984, May-12, Volume: 1, Issue:8385

    Topics: Cystic Fibrosis; Drug Hypersensitivity; Humans; Piperacillin

1984
Adverse reactions to piperacillin in patients with cystic fibrosis.
    Lancet (London, England), 1984, Jun-16, Volume: 1, Issue:8390

    Topics: Adolescent; Adult; Child; Cystic Fibrosis; Female; Humans; Male; Piperacillin; Pseudomonas Infections

1984
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Antimicrobial agents and chemotherapy, 1981, Volume: 20, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections

1981
Allergy to semisynthetic penicillins in cystic fibrosis.
    The Journal of pediatrics, 1984, Volume: 104, Issue:3

    Topics: Adolescent; Adult; Benzeneacetamides; Carbenicillin; Child; Cystic Fibrosis; Drug Hypersensitivity; Female; Humans; Intradermal Tests; Male; Penicillanic Acid; Penicillin G; Penicillins; Piperacillin; Polylysine; Pseudomonas Infections; Radioallergosorbent Test; Ticarcillin

1984
Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia.
    The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A

    Topics: Adolescent; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Pseudomonas Infections; Respiratory Tract Infections; Sulfamethoxazole; Tobramycin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination

1983
In vitro susceptibilities of mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients against azthreonam, netilmicin and piperacillin.
    Methods and findings in experimental and clinical pharmacology, 1984, Volume: 6, Issue:9

    Topics: Anti-Bacterial Agents; Aztreonam; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Netilmicin; Piperacillin; Pseudomonas aeruginosa

1984
Use of piperacillin, a semisynthetic penicillin, in the therapy of acute exacerbations of pulmonary disease in patients with cystic fibrosis.
    The Journal of pediatrics, 1980, Volume: 97, Issue:1

    Topics: Adolescent; Adult; Alcaligenes; Child; Cystic Fibrosis; Female; Humans; Kinetics; Lung Diseases; Male; Penicillins; Piperacillin; Pseudomonas Infections

1980
beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment.
    Antimicrobial agents and chemotherapy, 1981, Volume: 19, Issue:5

    Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carrier Proteins; Cystic Fibrosis; Female; Hexosyltransferases; Humans; Muramoylpentapeptide Carboxypeptidase; Penicillin G; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Piperacillin; Pseudomonas aeruginosa; Sputum; Tobramycin

1981
Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Scandinavian journal of infectious diseases. Supplementum, 1981, Volume: 29

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections

1981
Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
    European journal of respiratory diseases, 1982, Volume: 63, Issue:2

    Topics: Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Tobramycin

1982
Lectin-like factor and co-factor in serum from cystic fibrosis heterozygotes.
    The American journal of medicine, 1984, Volume: 77, Issue:4

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Chromatography, Gel; Cystic Fibrosis; Genetic Carrier Screening; Humans; Immunoglobulin M; Lectins; Piperacillin; Ticarcillin

1984
In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Child; Cystic Fibrosis; Drug Therapy, Combination; Humans; Kanamycin; Penicillin Resistance; Piperacillin; Pseudomonas Infections; Ticarcillin

1984
Ticarcillin-induced cystitis. Cross-reactivity with related penicillins.
    American journal of diseases of children (1960), 1984, Volume: 138, Issue:7

    Topics: Carbenicillin; Child; Child, Preschool; Cross Reactions; Cystic Fibrosis; Cystitis; Hematuria; Humans; Male; Penicillins; Piperacillin; Ticarcillin

1984
Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1994, Volume: 102, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbenicillin; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Denmark; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Piperacillin; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

1994
Coagulopathy with piperacillin administration in cystic fibrosis: two case reports.
    Journal of paediatrics and child health, 1994, Volume: 30, Issue:3

    Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Child; Child, Preschool; Cystic Fibrosis; Drug Eruptions; Female; Humans; Liver Function Tests; Piperacillin; Serum Sickness

1994
Antibiotic hypersensitivity reactions in cystic fibrosis.
    Journal of paediatrics and child health, 1998, Volume: 34, Issue:4

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Drug Administration Routes; Drug Hypersensitivity; Female; Humans; Infant; Male; Penicillins; Piperacillin; Respiratory Tract Infections; Retrospective Studies

1998
Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:2

    Topics: Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Rifampin; Thienamycins; Tobramycin

1999
Haemolytic anaemia following treatment with piperacillin in a patient with cystic fibrosis.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:3

    Topics: Adult; Anemia, Hemolytic; Cystic Fibrosis; Female; Humans; Penicillins; Piperacillin

1999
Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 30, Issue:5

    Topics: Burkholderia cepacia; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Tobramycin

1992
New peripherally inserted midline catheter: a better alternative for intravenous antibiotic therapy in patients with cystic fibrosis.
    Pediatric pulmonology, 1992, Volume: 12, Issue:4

    Topics: Adolescent; Adult; Catheterization, Peripheral; Catheters, Indwelling; Ceftazidime; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Elbow; Female; Humans; Imipenem; Infusions, Intravenous; Male; Piperacillin; Time Factors; Tobramycin

1992
Optimal sampling theory and population modelling: application to determination of the influence of the microgravity environment on drug distribution and elimination.
    Journal of clinical pharmacology, 1991, Volume: 31, Issue:10

    Topics: Bayes Theorem; Ceftazidime; Chromatography, High Pressure Liquid; Ciprofloxacin; Cystic Fibrosis; Fever; Humans; Models, Theoretical; Monte Carlo Method; Neoplasms; Neutropenia; Pharmacokinetics; Piperacillin; Population; Sampling Studies; Weightlessness

1991
Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Bronchopneumonia; Child; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Cystic Fibrosis; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Kinetics; Male; Microbial Sensitivity Tests; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Thienamycins; Tobramycin

1987
Decreased baseline beta-lactamase production and inducibility associated with increased piperacillin susceptibility of Pseudomonas cepacia isolated from children with cystic fibrosis.
    Pediatric research, 1986, Volume: 20, Issue:11

    Topics: Analysis of Variance; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefoxitin; Ceftazidime; Child; Cystic Fibrosis; Humans; Isoelectric Focusing; Penicillin Resistance; Piperacillin; Pseudomonas; Sputum

1986
Penetration of latamoxef, cefoperazone and piperacillin into the sputum of patients with cystic fibrosis.
    Chemotherapy, 1985, Volume: 31, Issue:4

    Topics: Adolescent; Adult; Cefoperazone; Child; Child, Preschool; Cystic Fibrosis; Humans; Hydrogen-Ion Concentration; Moxalactam; Piperacillin; Pseudomonas aeruginosa; Sputum

1985
Antibacterial activity in vitro of sulbenicillin against mucoid and non-mucoid strains of Pseudomonas aeruginosa.
    Drugs under experimental and clinical research, 1985, Volume: 11, Issue:4

    Topics: Ampicillin; Carbenicillin; Cefotaxime; Cystic Fibrosis; Humans; Methods; Microbial Sensitivity Tests; Penicillin G; Piperacillin; Pseudomonas aeruginosa; Sulbenicillin

1985
Adverse reactions to piperacillin in adults with cystic fibrosis.
    Thorax, 1985, Volume: 40, Issue:3

    Topics: Adult; Azlocillin; Carbenicillin; Cystic Fibrosis; Female; Fever; Humans; Male; Piperacillin; Pseudomonas Infections; Respiratory Tract Infections

1985